Versa Vascular

Santa Cruz, United States

Versa Vascular is a developer of an implant system designed to treat tricuspid regurgitation by supporting native valve function.

$27.3M raised

Jul 2025

Series C

Health Care Manufacturing Medical Device

Top Investors

Santa Cruz Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Versa Vascular

How much funding has Versa Vascular raised?

Versa Vascular has raised $27.3M in total funding. The most recent round was Series C. The last funding was announced in July 2025.

Who are Versa Vascular's investors?

Versa Vascular's investors include Santa Cruz Ventures.

Where is Versa Vascular headquartered?

Versa Vascular is headquartered in Santa Cruz, United States.

What does Versa Vascular do?

Versa Vascular is a developer of an implant system designed to treat tricuspid regurgitation by supporting native valve function.

What stage is Versa Vascular at?

Versa Vascular is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 30, 2025.

MLA

"Versa Vascular — Funding & Investors." VCBacked, July 30, 2025, https://www.vcbacked.co/company/versa-vascular. Accessed July 2, 2026.

APA

VCBacked. (2025). Versa Vascular — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/versa-vascular

Wikipedia (cite web)

{{cite web |title=Versa Vascular — Funding & Investors |url=https://www.vcbacked.co/company/versa-vascular |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 30, 2025.

Similar Companies in Health Care

View all

Oryl Photonics

Lausanne

Allterum Therapeutics

Circl Brain Health Metrics

Victoria$354K

YLAH

Bern$589K